Investor Overview Recent News Mar 30, 2020 Summary ToggleAgios Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Mitapivat in Pyruvate Kinase Deficiency full article Mar 25, 2020 Summary ToggleAgios Provides Update on 2016 Collaboration Agreement with Celgene, a Wholly Owned Subsidiary of Bristol Myers Squibb full article Mar 23, 2020 Summary ToggleAgios Announces FDA Clearance of Investigational New Drug Application for AG-946, a Next-Generation PKR Activator full article Feb 18, 2020 Summary ToggleAgios to Present at the Cowen 40th Annual Healthcare Conference on Tuesday, March 3, 2020 full article Feb 13, 2020 Summary ToggleAgios Reports Fourth Quarter and Full Year 2019 Financial Results full article Feb 11, 2020 Summary ToggleAgios to Present at the Leerink 9th Annual Global Healthcare Conference on Tuesday, February 25, 2020 full article View All Events & Presentations Mar 3, 2020 at 11:20 AM EST Agios at Cowen 40th Annual Healthcare Conference full article Feb 25, 2020 at 10:30 AM EST Agios at Leerink 9th Annual Global Healthcare Conference full article Feb 13, 2020 at 8:00 AM EST Q4 2019 Agios Pharmaceuticals Inc Earnings Conference Call Supporting Materials: Fourth Quarter 2019 Financial Results Presentation 1.7 MB full article View All Analyst Coverage Firm Analyst Needham & Company Chad Messer Ph.D. Oppenheimer & Co. Mark Breidenbach Ph.D. Piper Sandler Tyler Van Buren RBC Capital Markets Kennen MacKay Pagination First page First Previous page Previous Page 1 Current page 2 Stock Information Price: Change: Volume: (Common Stock) Data as of Apr 10, 2020 5:07 am EDT Copyright West LLC. Minimum 15 minutes delayed.
Feb 13, 2020 at 8:00 AM EST Q4 2019 Agios Pharmaceuticals Inc Earnings Conference Call Supporting Materials: Fourth Quarter 2019 Financial Results Presentation 1.7 MB